comparemela.com

Shore Capital reiterated their house stock rating on shares of Destiny Pharma (LON:DEST – Free Report) in a report released on Wednesday, MarketBeat.com reports. Destiny Pharma Stock Performance Shares of LON DEST opened at GBX 50.50 ($0.63) on Wednesday. The business has a fifty day simple moving average of GBX 47.49 and a 200 day […]

Related Keywords

United Kingdom , ,Destiny Pharma Company Profile ,Shore Capital ,Destiny Pharma ,Free Report ,Get Free Report ,Destiny Pharma Daily ,Lon Dest ,Odest ,Medical ,Reiterated Rating ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.